Company intelligence / Profile preview

SEREN Pharmaceuticals

Ownership
Private
Development stage
Other
01

Overview

SEREN Pharmaceuticals is a private pharmaceutical company focusing on clinical development with a business model centered on in-licensing development candidates from pharmaceutical companies where Proof of Concept (POC) has been confirmed, and efficiently developing them with a small but highly specialized team.

Industry
Biotech
02

Drug pipeline

2 assets

TKT001-S

Preclinical

1 more asset in the full pipeline.

Beyond the preview

Go deeper on SEREN Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SEREN Pharmaceuticals.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call